½ÃÀ庸°í¼­
»óǰÄÚµå
1596342

¼¼°èÀÇ ÈäÅÍ Ä¡·á ½ÃÀå : Á¦Ç° À¯Çüº°, ÈäÅÍ À¯Çüº°, ÃÖÁ¾ ¿ëµµº° - ¿¹Ãø(2025-2030³â)

Scar Treatment Market by Product (Injectables, Laser Products, Topical Products), Scar Type (Atrophic Scars, Contracture Scars, Hypertrophic & Keloid Scars), End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÈäÅÍ Ä¡·á ½ÃÀåÀº 2023³â¿¡ 371¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 442¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 19.21%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 1,271¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÈäÅÍ Ä¡·á ½ÃÀå¿¡´Â ºñÈļº ÈäÅÍ, ÄÌ·ÎÀ̵å ÈäÅÍ, À§Ã༺ ÈäÅÍ, ±¸Ã༺ ÈäÅÍ µî ´Ù¾çÇÑ À¯ÇüÀÇ ÈäÅÍÀÇ ¿ÜÇüÀ» ÃÖ¼ÒÈ­Çϰųª ´«¿¡ ¶çÁö ¾Ê°ÔÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ ¾öû³­ ¼ö Á¦Ç° ¹× Á¶Ä¡°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ ¼ºÀå ½ÃÀåÀº ÈäÅͰ¡ ½É¸®Àû ºÎ´ãÀ̳ª ½ÅüÀû ºÒÄè°¨À» ÀÏÀ¸Å³ ¼ö Àֱ⠶§¹®¿¡ ¹Ì¿ë°ú °Ç°­ÀÇ ¾ç¸é¿¡¼­ °³¼±ÀÇ Çʿ伺¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. Ä¡·á´Â ¿Ü¿ë¾×, ·¹ÀÌÀú Ä¡·á, ¿Ü°úÀû °³ÀÔºÎÅÍ ¸¶ÀÌÅ©·Î´Ïµé, ´ÙÇ÷¼ÒÆÇ Ç÷ÀåÄ¡·á¿Í °°Àº »õ·Î¿î ±â¼ú±îÁö ´Ù¹æ¸é¿¡ °ÉĨ´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â °³ÀÎ ¼ÒºñÀÚ, Ŭ¸®´Ð, ÇǺΰú ¼¾ÅÍ, º´¿ø µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº Àúħ½À Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ´ë, °¡Ã³ºÐ¼Òµæ Áõ°¡, ¼Ò¼È ¹Ìµð¾î¿Í À¯¸íÀÎÀÇ Ãßõ¿¡ ÀÇÇÑ ÀÎÁöµµ Áõ°¡ µîÀÇ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â Ä¡·á ¿É¼ÇÀÇ ±â¼úÀû Áøº¸, ³ëÀÎ Àα¸ Áõ°¡, ¿Ü»ó Áõ°¡, ÇǺΠ°ü·Ã Áúȯ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï½ÃÀå ÁøÃâ, Á¦Ç°Çõ½ÅÀ» À§ÇÑ ¿¬±¸°³¹ß °­È­, °³º°È­µÈ ÈäÅÍ Ä¡·á¿Í º´¿ë Ä¡·á¿¡ ´ëÇÑ ÁÖ·Â µîÀÌ ±âȸÀÔ´Ï´Ù. ±×·¯³ª °í¾×ÀÇ Ä¡·áºñ, ºÎÀÛ¿ë °¡´É¼º, º¸Çèȸ»ç¿¡ ÀÇÇÑ »óȯ Á¦ÇѰú °°Àº °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±ÔÁ¦ »óȲÀ̳ª ´Ù¾çÇÑ ÇǺΠ¹× Àα¸ µ¿Å ¿äÀεµ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ±â¼úÇõ½ÅÀº º¸´Ù ¿ì¼öÇÑ À¯È¿¼º°ú ¾ÈÀü¼ºÀ» È®º¸Çϱâ À§ÇØ »ýüÀûÇÕ¼º Àç·á, ·¹ÀÌÀú ¹× ±¤Ä¡·á Àåºñ °³¼±, ±¹¼Ò Ä¡·á¿ë »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛ µî¿¡ ÁýÁßÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϰí, ¼ÒºñÀÚ ÁÖµµÇüÀ̱⠶§¹®¿¡ Àü·« ¸ñÇ¥¸¦ ¼ÒºñÀÚ ¿ä±¸¿Í ÀÏÄ¡½ÃÄÑ, Æø³ÐÀº ¸®Ä¡¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇØ, µðÁöÅÐ ¸¶ÄÉÆÃ È°µ¿À» °­È­ÇÏ°í °í°´ ±³À°À» ¼±È£ÇÏ´Â °ÍÀÌ ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁøÈ­ÇÏ´Â ¼ÒºñÀÚÀÇ ±âÈ£¿Í ±â¼úÀÇ Áøº¸¿¡ °è¼Ó ´ëÀÀÇÏ´Â ±â¾÷Àº, ÀÌ ´ÙÀ̳ª¹ÍÇÑ ½ÃÀå¿¡¼­ ÃÖ´ëÀÇ Á¡À¯À²À» ȹµæÇÏ´Â ÀÔÀå¿¡ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 371¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 442¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 1,271¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 19.21%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÈäÅÍ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÈäÅÍ Ä¡·á ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÇǺÎÁúȯÀÌ ³ôÀº ¸¸¿¬
    • ±³Åë»ç°í³ª È­»ó¿¡ ÀÇÇÑ ÀÔ¿ø·ü Áõ°¡
    • °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ¿Ü°ß ÀÇ½Ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÈäÅÍ Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ±â¼úÀûÀ¸·Î Áøº¸ÇÑ ÈäÅÍ Ä¡·áÀÇ µµÀÔ
    • ÈäÅÍ Ä¡·á¿¡ °üÇÑ °³ÀÎÀÇ ÀǽÄÀÇ °íÁ¶
  • ½ÃÀåÀÇ °úÁ¦
    • ÈäÅÍ Ä¡·áÀÇ ºÎÀÛ¿ë

Porter's Five Forces : ÈäÅÍ Ä¡·á ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÈäÅÍ Ä¡·á ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÈäÅÍ Ä¡·á ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÈäÅÍ Ä¡·á ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÈäÅÍ Ä¡·á ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÈäÅÍ Ä¡·á ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÈäÅÍ Ä¡·á ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÈäÅÍ Ä¡·á ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸®±â

ÈäÅÍ Ä¡·á ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â, ½ÇÀû ÁöÇ¥¸¦ Àç°ËÅäÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇØ, °³¼±¿¡ ÀÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï Á¤¼¼ÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÎ±â À§ÇÑ Ã¼Á¦¸¦ °®Ãâ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÇǺÎÁúȯÀÇ ³ôÀº À¯º´·ü
      • ±³Åë»ç°í³ª È­»ó¿¡ ÀÇÇÑ ÀÔ¿ø·ü Áõ°¡
      • °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ¿Ü°ß ÀǽÄ
    • ¾ïÁ¦¿äÀÎ
      • ÈäÅÍ Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • ±â¼úÀûÀ¸·Î Áøº¸ÇÑ ÈäÅÍ Ä¡·áÀÇ µµÀÔ
      • ÈäÅÍ Ä¡·á¿¡ °üÇÑ °³ÀÎÀÇ ÀÇ½Ä °íÁ¶
    • °úÁ¦
      • ÈäÅÍ Ä¡·áÀÇ ºÎÀÛ¿ë
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÈäÅÍ Ä¡·á ½ÃÀå : Á¦Ç°º°

  • ÁÖ»çÁ¦
  • ·¹ÀÌÀú Á¦Ç°
    • CO2 ·¹ÀÌÀú
    • ÆÞ½º ´ÙÀÌ ·¹ÀÌÀú
  • ±¹¼Ò¿ë Á¦Ç°
    • Å©¸²
    • Á©
    • ½Ç¸®ÄÜ ½ÃÆ®

Á¦7Àå ÈäÅÍ Ä¡·á ½ÃÀå : ÈäÅÍ À¯Çüº°

  • À§Ã༺ ÈäÅÍ
  • ±¸Ãà ÈäÅÍ
  • ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ
  • ½ºÆ®·¹Ä¡ ¸¶Å©

Á¦8Àå ÈäÅÍ Ä¡·á ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • Ŭ¸®´Ð
  • º´¿ø
  • ¾à±¹ ¶Ç´Â ÀüÀÚ»ó°Å·¡

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÈäÅÍ Ä¡·á ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÈäÅÍ Ä¡·á ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÈäÅÍ Ä¡·á ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Absolute MS
  • Allergan PLC
  • Alliance Pharma
  • Avita Medical Limited
  • Avocet Polymer Technologies
  • Bausch Health Companies Inc.
  • Biodermis
  • CCA Industries, Inc.
  • McKesson Medical-Surgical Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Quantum Health
  • Revitol Corporation Inc.
  • Scarguard Labs
  • Smith & Nephew PLC
  • Valeant Pharmaceuticals International Inc.
AJY 24.12.02

The Scar Treatment Market was valued at USD 37.17 billion in 2023, expected to reach USD 44.28 billion in 2024, and is projected to grow at a CAGR of 19.21%, to USD 127.19 billion by 2030.

The scar treatment market encompasses a vast array of products and procedures aimed at minimizing or eliminating the appearance of various types of scars, such as hypertrophic, keloid, atrophic, and contracture scars. This growing market addresses the necessity for both cosmetic and health-related improvements, given the psychological burden and physical discomfort scars can cause. Applications range from topical solutions, laser therapy, and surgical interventions to novel technologies like microneedling and platelet-rich plasma treatments. The end-use scope includes individual consumers, clinics, dermatology centers, and hospitals. The market benefits from a rising demand for minimally invasive treatments, increasing disposable incomes, and heightened awareness due to social media and celebrity endorsements. Key growth influencers include technological advancements in treatment options, a growing geriatric population, an increase in traumatic injuries, and skin-related disorders. Opportunities lie in expanding into emerging markets, strengthening R&D for product innovation, and focusing on personalized scar therapies and combination treatments. However, challenges such as high treatment costs, potential side effects, and limited reimbursement from insurance companies can impede market growth. The regulatory landscape and diverse skin and demographic factors also pose challenges. Innovation could focus on biocompatible materials, improvements in laser and light therapy devices, and new drug delivery systems for topical treatments to ensure better efficacy and safety. As the market is highly competitive and consumer-driven, aligning strategic goals with consumer needs, cultivating partnerships for broader reach, enhancing digital marketing efforts, and prioritizing client education are essential for growth. Companies that stay attuned to evolving consumer preferences and technological advancements stand to capture the maximum share in this dynamic market.

KEY MARKET STATISTICS
Base Year [2023] USD 37.17 billion
Estimated Year [2024] USD 44.28 billion
Forecast Year [2030] USD 127.19 billion
CAGR (%) 19.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Scar Treatment Market

The Scar Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of skin diseases
    • Increased hospital admission rates owing to road accidents and burns
    • Rising disposable income and appearance consciousness
  • Market Restraints
    • High cost associated with scar treatment
  • Market Opportunities
    • Introduction of technologically advanced scar treatments
    • Growing awareness among individuals about scar treatment
  • Market Challenges
    • Side effects of scar treatments

Porter's Five Forces: A Strategic Tool for Navigating the Scar Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Scar Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Scar Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Scar Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Scar Treatment Market

A detailed market share analysis in the Scar Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Scar Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Scar Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Scar Treatment Market

A strategic analysis of the Scar Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Scar Treatment Market, highlighting leading vendors and their innovative profiles. These include Absolute MS, Allergan PLC, Alliance Pharma, Avita Medical Limited, Avocet Polymer Technologies, Bausch Health Companies Inc., Biodermis, CCA Industries, Inc., McKesson Medical-Surgical Inc., Merz Pharma GmbH & Co. KGaA, Quantum Health, Revitol Corporation Inc., Scarguard Labs, Smith & Nephew PLC, and Valeant Pharmaceuticals International Inc..

Market Segmentation & Coverage

This research report categorizes the Scar Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Injectables, Laser Products, and Topical Products. The Laser Products is further studied across CO2 Laser and Pulse-Dyed Laser. The Topical Products is further studied across Creams, Gels, and Silicon Sheets.
  • Based on Scar Type, market is studied across Atrophic Scars, Contracture Scars, Hypertrophic & Keloid Scars, and Stretch Marks.
  • Based on End-Use, market is studied across Clinics, Hospitals, and Retail Pharmacies or E-Commerce.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of skin diseases
      • 5.1.1.2. Increased hospital admission rates owing to road accidents and burns
      • 5.1.1.3. Rising disposable income and appearance consciousness
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with scar treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced scar treatments
      • 5.1.3.2. Growing awareness among individuals about scar treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects of scar treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Scar Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Injectables
  • 6.3. Laser Products
    • 6.3.1. CO2 Laser
    • 6.3.2. Pulse-Dyed Laser
  • 6.4. Topical Products
    • 6.4.1. Creams
    • 6.4.2. Gels
    • 6.4.3. Silicon Sheets

7. Scar Treatment Market, by Scar Type

  • 7.1. Introduction
  • 7.2. Atrophic Scars
  • 7.3. Contracture Scars
  • 7.4. Hypertrophic & Keloid Scars
  • 7.5. Stretch Marks

8. Scar Treatment Market, by End-Use

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals
  • 8.4. Retail Pharmacies or E-Commerce

9. Americas Scar Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Scar Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Scar Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Absolute MS
  • 2. Allergan PLC
  • 3. Alliance Pharma
  • 4. Avita Medical Limited
  • 5. Avocet Polymer Technologies
  • 6. Bausch Health Companies Inc.
  • 7. Biodermis
  • 8. CCA Industries, Inc.
  • 9. McKesson Medical-Surgical Inc.
  • 10. Merz Pharma GmbH & Co. KGaA
  • 11. Quantum Health
  • 12. Revitol Corporation Inc.
  • 13. Scarguard Labs
  • 14. Smith & Nephew PLC
  • 15. Valeant Pharmaceuticals International Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦